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Polyphenols are known for their antimicrobial activity, whilst both polyphenols and the globular protein beta-30 
lactoglobulin (bLG) are suggested to have antioxidant properties and to promote cell proliferation. These are 31 
potentially useful properties to have as part of a tissue engineered construct, though it is unknown if they are 32 
retained when both compounds are used in combination. In this study, a range of different microbes and an 33 
osteoblast-like cell line (hFOB) were used to assess the combined effect of; (1) a green tea extract (GTE), rich in 34 
the polyphenol epigallocatechin gallate (EGCG), and (2) a whey protein isolate (WPI), rich in bLG. It was 35 
shown that approximately 20–48 % of the EGCG in GTE reacted with WPI. GTE inhibited the growth of gram-36 
positive bacteria, an effect which was potentiated by the addition of WPI. GTE alone also significantly inhibited 37 
the growth of hFOB cells after 1, 4 and 7 days of culture. Alternatively, WPI significantly promoted hFOB cell 38 
growth in the absence of GTE and attenuated the effect of GTE at low concentrations (64 µg/ml), after 4 and 7 39 
days. Low concentrations of WPI (50 µg/ml) also promoted expression of the early osteogenic marker alkaline 40 
phosphatase (ALP) by hFOB cells, whereas GTE inhibited alkaline phosphatase ALP activity. Therefore, the 41 
antioxidant effects of GTE can be boosted by WPI, but it is not suitable to be used as part of a tissue-engineered 42 
construct due to its cytotoxic effects which negate any positive effect of WPI on cell proliferation.   43 
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ALP = alkaline phosphatase 48 
ANOVA = one-way analysis of variance 49 
ATCC = the American Type Culture Collection 50 
bLG = beta-lactoglobulin 51 
BOF = Bijzonder Onderzoeksfonds (Special Research Fund) 52 
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DAD = diode array detector 54 
ddH2O = sterile ultra-pure water 55 
DFG = Deutsche Forschungsgemeinschaft (German Research Foundation) 56 
DMEM = Dulbecco´s modified Eagle medium 57 
DNA = deoxyribonucleic acid 58 
DPPH = 2,2-diphenyl-1-picrylhydrazyl 59 
EC = epicatechin 60 
ECG = epicatechingallate 61 
EGC = epigallocatechine 62 
EGCG = epigallocatechin gallate 63 
EUCAST = The European Committee on Antimicrobial Susceptibility Testing 64 
FRAP = ferric reducing ability of plasma 65 
FWO = Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (Research Foundation- Flanders) 66 
GTE = green tea extract 67 
hFOB = human foetal osteoblast 68 
HPLC = high performance liquid chromatography 69 
MgCl2 = magnesium chloride 70 
MH broth = Mueller-Hinton broth 71 
MIC = minimal inhibitory concentration 72 
MRSA = methicillin-resistant Staphylococcus aureus 73 
NaCl = sodium chlorid 74 
NaOH = sodium hydroxide 75 
PBS = phosphate buffered saline 76 
ROS = reactive oxygen species 77 
RPMI medium = Roswell Park Memorial Institute medium 78 
S.D. = standard deviation 79 
TEAC = Trolox equivalent antioxidant capacity 80 
TFA = triﬂuoracetic acid 81 






Antibacterial properties are highly desirable characteristics for bone regeneration materials, especially 88 
in oral and maxillofacial surgery due to the high microbial load of the oral cavity (George et al. 1994; Chen et 89 
al. 2010; Gosau et al. 2016). Due to the increasing occurrence of antibiotic-resistant bacteria, such as 90 
methicillin-resistant Staphylococcus aureus (MRSA) (Klein et al. 2016; Kavanagh et al. 2017), there is a 91 
pressing need to find alternative low cost antibacterial agents, to which there is little resistance.  92 
Green tea extract (GTE) is known to be rich in polyphenols, which in turn possess antibacterial activity 93 
(Zhao et al. 2001; Gharib et al. 2013) (for a review see (Steinmann et al. 2013)). One major polyphenol of GTE 94 
is epigallocatechin gallate (EGCG), which shows antibacterial activity against MRSA (Gharib et al. 2013) and is 95 
alleged to stimulate the growth and differentiation of bone-forming cells (Vali et al. 2007; Jin et al. 2014). To 96 
improve stability of EGCG, it is commonly combined with carrier proteins, such as the globular protein beta -97 
lactoglobulin (bLG) (Keppler et al. 2015). bLG is a major component of whey protein isolate (WPI), derived 98 
from milk. It consists of 162 amino acid residues, has a molecular weight of approximately 18.4 kDa and is 99 
known to be able to bind hydrophobic molecules (Kontopidis et al. 2004). Besides its application as a carrier 100 
protein, bLG has been reported to improve the proliferation of various mammalian cells (Moulti-Mati et al. 101 
1991; Mahmud et al. 2004; Gillespie et al. 2015). It is therefore hypothesised that bLG would also positively 102 
influence osteoblast growth, which would be desirable for bone regeneration applications.  103 
Oxidative stress plays an important role in the immune response and has been identified as a 104 
pathological inducer in almost all organs (Wauquier et al. 2009). Despite its role in cell signaling, an increased 105 
level of oxidative stress can cause bone loss, leading to conditions such as osteoporosis, bone tumor 106 
development and inappropriate ingrowth of bone implants. Furthermore, increased levels of reactive oxygen 107 
species (ROS) have a supportive effect on osteoclasts, the cells responsible for bone resorption (Garrett et al. 108 
1990; Bai et al. 2005). Thus, antioxidant activity of compounds used during bone substitution could conceivably 109 
improve the stability of an implant. EGCG and bLG both have antioxidant activity, which make them excellent 110 
candidates as loading agents for bone tissue regeneration (Tong et al. 2000; Tobi et al. 2002; Mann et al. 2015). 111 
Although there is some data available on the micro and cell biological effects of GTE, WPI and their 112 
components, the effects of GTE and WPI in combination remain unexplored. It was therefore hypothesized that 113 
WPI would influence GTE’s antimicrobial and antioxidant activity, as well as its impact on osteoblast 114 
growth/differentiation. In the present study, chemical interaction of GTE and WPI was analyzed by 115 
centrifugation, ultrafiltration and subsequent high performance liquid chromatography (HPLC) analyses. 116 
Antimicrobial activity was tested against a range of bacteria (both Gram-positive and Gram-negative) and fungi, 117 
whilst effects on osteoblast proliferation and differentiation were tested using an osteoblastic cell line. Finally, 118 
antioxidant properties were investigated using the DPPH (2,2-diphenyl-1-picrylhydrazyl) method. GTE has 119 
substantial antimicrobial and antioxidant capability and binds to WPI, which displayed positive effects on 120 
osteoblast activity.  121 
 122 
Materials and Methods 123 
Materials 124 
Unless stated otherwise, all reagents were obtained from Sigma-Aldrich. WPI (BiPRO, Davisco Foods 125 
International, Inc., Eden Prairie, US) with 97.7% protein and 75% bLG in dry matter (according to 126 
specification) was used as previously described (Serfert et al. 2014; Keppler et al. 2017). GTE, > 95% (obtained 127 
from green tea leaves, catechins content>75%, EGCG>65%; according to specification) was purchased from 128 
Oskar Tropitzsch e. K. (Marktredwitz, Germany). 129 
 130 
Material analysis 131 
Analysis of WPI 132 
The composition of the WPI was determined using a method described previously (Clawin-Radecker et al. 133 
2000; Keppler et al. 2014). Briefly, a HPLC HP 1100 system (Agilent Technology, Germany) equipped with a 134 
PLRP-S 300 Å 8 μm, 150 × 4.6 mm column (Polymer Laboratories, Varian, Inc.) and a diode array detector 135 
(DAD) at 205 nm wavelengths was used. Eluent A was 0.1% triﬂuoracetic acid (TFA) in wa ter and eluent B was 136 
0.1% TFA in acetonitrile. The following gradient was used: 0 min, 35% B; 1 min, 35% B; 8 min, 38% B; 16 137 
min, 42% B; 22 min, 46% B; 22.5 min, 100% B; 23 min, 100% B and 23.5–30 min, 35% B. Flow rate was 1 138 
ml/min, the injection volume was 20 ml and the column temperature was set to 40 °C. Standards of bovine 139 
serum albumin, alpha-lactalbumin and beta-lactoglobulin were run for identification. 140 
Analysis of GTE 141 
GTE was analysed by HPLC (Agilent 1100, with a DAD at 280 nm wavelength) using a C18-Nucleodur Sphinx 142 
125/4 reversed phase column, 5 µm (Macherey-Nagel GmbH & Co. KG, Düren, Germany). Eluent A consisted 143 
of water with 0.1 % formic acid, whilst eluent B was acetonitrile with 0.1 % formic acid. The following gradient 144 
was used: 0-1 min, 5 % B; 1-10 min, 95 % B; 10-10.5 min, 95 % B; 10.5 – 11 min, 5 % B and 11-12 min, 5 % 145 
B. Standards of the GTE components (EGCG, epigallocatechine (EGC), epicatechingallate (ECG) and 146 
epicatechin (EC)) were run to identify the respective signals in the GTE. Percentage composition of the 147 
components was assessed semiquantitatively, by comparing individual peak areas to the sum of all peak areas.  148 
 149 
Binding studies 150 
For binding analysis, approximately 4 mg/ml WPI in water were weighed together with GTE in a concentrat ion 151 
ratio of 1:0.08 g (w/w), 1:0.16 g (w/w), 1:0.32 g (w/w) and 1:0.64 g (w/w). Subsequently, samples were 152 
dissolved in demineralized water for 30min at room temperature with vigorous stirring. For control, solutions of 153 
GTE without WPI were prepared at a similar concentration. Vivaspin 2 centrifugal filtration devices 154 
(Hydrosart® regenerated cellulose membrane, 10 kDa), from Sartorius AG (Göttigen, Germany), were rinsed 155 
with 2ml demineralized water. Following this, 1ml of the respective sample solution (i.e. GTE with and without 156 
WPI) was centrifuged, using 4000*g for 2 min at 20 °C - in a swinging-bucket rotor centrifuge. The filtrate and 157 
remaining retentate were discarded and replaced again by 1 ml of sample solution. After centrifugation, the 158 
filtrate was analysed via HPLC, using the aforementioned method for GTE analysis. As controls, uncentrifuged 159 
GTE samples were also analysed, to determine the amount of GTE lost in the membrane during filtration.  160 
 161 
Antioxidant method (DPPH test) 162 
The radical scavenging activity of the different WPI/GTE complexes was analysed using a modification of the 163 
DPPH test described by Harbaum et al. (Harbaum et al. 2008). The DPPH assay was carried out by mixing 1 mL 164 
of 0.3 mmol/L 2,2-diphenyl-1-picrylhydrazyl (DPPH radical) in ethanol with 1.95 mL of 25% aqueous ethanol , 165 
containing 0.1 M phosphate buffered saline (PBS) buffer. This gave a ﬁnal 50% ethanolic solution. An initial 166 
reading was carried out at 516 nm (initial absorbance approximately 1.3). Subsequently, a 50 µL sample (also 167 
dissolved in ethanol) was added, and the absorbance was measured after 10 minutes of reaction time. The 168 
antioxidative capacity was given as % inhibition: %inh = ([A0-A1]/A0) *100, where A0 is the initial absorbance 169 
of the standard and A1 is the absorbance of the sample. 170 
 171 
Antibacterial studies 172 
Staphylococcus aureus ATCC 700699, ET199 and LMG10147, Staphylococcus epidermidis ET086 and P. 173 
aeruginosa ATCC9027 were cultured aerobically in Mueller-Hinton broth (MH; Oxoid, Basingstoke, England), 174 
at 37°C. Propionibacterium acnes LMG 16711 was cultured anaerobically in Reinforced clostridial medium 175 
(RCM; Oxoid), at 37°C. Candida albicans ATCC MYA-2876 was cultured aerobically in RPMI 1640 medium 176 
(Sigma-Aldrich, Diegem, Belgium), at 37°C. 177 
Determination of the Minimal Inhibitory Concentration (MIC): MIC of GTE alone or in the presence of WPI  178 
(50 or 800 µg/ml) was determined according to the EUCAST broth microdilution protocol, using f lat-bottom 179 
96-well microtiter plates (TPP, Trasadingen, Switzerland). The inoculum was standardized to approximately 5 × 180 
105 colony forming units (CFU)/ml. The concentration of GTE tested ranged from 0.5 - 1024 µg/ml. The plates 181 
were incubated at 37°C for 24 h, and the optical density at 590 nm was determined using a multilabel microtiter 182 
plate reader (Envision; Perkin-Elmer LAS, Waltham, MA). MIC was recorded as the lowest concentration of 183 
GTE, alone or in combination with WPI, which displayed a similar optical density as that observed in inoculated 184 
and blank wells. 185 
 186 
Cytocompatibility testing using fibroblasts  187 
Human fibroblasts were isolated from the gingiva of seven patients (4 female, aged 21, 25, 20 and 20 years and 188 
3 male, aged 36, 21 and 21 years) cultured in cell culture medium (Eagle’s minimum essential Medium Alpha 189 
modification (Sigma-Aldrich GmbH, Hamburg, Germany), antibiotics (100 U x mL-1 Penicillin, 100 µg x mL-1 190 
Streptomycin, Biochrom, Berlin, Germany), 1 % Amphotericin (Biochrom), 15 % fetal bovine serum (FBS) 191 
(HyClone, Logan, Utah, USA) and 400 mmol x ml-1 L-Glutamine) for 7 days, then medium was exchanged 192 
three times per week Ethical approval (number D444/10) was obtained from University Hospital Schleswig-193 
Holstein, Campus Kiel, Germany. Fibroblasts in the third passage were pooled and 5x103 were seeded in 96-194 
well plates, i.e. 1.56 x 104 cells/cm2. Cytocompatibility was assessed by incubating cells with medium 195 
containing 0, 50 or 800 µg/ml WPI and 0, 64, 128, 256, 512, 1024, 2048 or 4096 µg/m l GTE. Morphology was 196 
assessed by light microscopy after 7 days of culture. Medium was changed 3 times during this period. 197 
 198 
Cytocompatibility testing using hFOB osteoblast-like cells 199 
An immortalized human foetal osteoblast (hFOB) cell line (hFOB 1.19; LGC Standards, USA) was used in this 200 
study, cultured in Dulbecco’s modified Eagle medium (DMEM)/F12 (1:1) medium, supplemented with 10% 201 
FBS, 1% L-glutamine and 0.6% geneticin (all Gibco, Life Technologies, UK). Treatments were prepared at 202 
concentrations detailed in section 2.6, filter sterilised (0.22 µm) before use and protected from light. Cells were 203 
seeded at 1x105 cells/cm2 on 96-well sterile culture plates and given a 24 hour settling period before treatment. 204 
For all experimental conditions n=4. 205 
 206 
hFOB proliferation 207 
Proliferation was measured by crystal violet staining at 1, 4 and 7 days. After removing culture medium by 208 
aspiration, cells were fixed with 100µl of 4% paraformaldehyde solution for 1 hr at room temperature, washed 209 
twice with ddH2O and left to air dry. Cell monolayers were then stained for 30 minutes at room temperature 210 
with 100µl of crystal violet solution per well (0.1% concentration), washed twice again in ddH2O and air dried. 211 
Finally, the dye was extracted from monolayers by the addition of 100µl of 1M acidified methanol. Absorbance 212 
was read at 585nm using a Tecan GENios microplate reader, and blanked using acidified methanol.  213 
hFOB differentiation 214 
Alkaline phosphatase (ALP), an enzyme produced by maturing osteoblasts, was used as an indicator  of cell 215 
differentiation. Briefly, cells were grown in complete medium supplemented with 10µM β-glycerophosphate 216 
and 50µM ascorbate-2-phosphate for 7, 14 or 21 days, before being washed with an alkaline buffer solution (5M 217 
NaCl, 1M Tris-Cl pH 9.5, 1M MgCl2). Cells were lysed by addition of 250µl of buffer - containing 0.2% Triton 218 
X-100 - and left to gently mix for 20 minutes on ice, before being stored at -80°C. Upon testing, 50 µl from each 219 
well was added to a test plate in duplicate. 200 µl of conditioned medium, consisting of alkaline buffer solution 220 
(Sigma) and p-nitrophenyl phosphate substrate was added to each well. Each test plate was then covered in foil 221 
and incubated for 30min at 37°C, allowing the coupled enzymatic reaction to proceed. The reaction  was stopped 222 
by the addition of 50µl of stop solution (3M NaOH) and absorbance was read at 450nm. Finally, ALP readings 223 
were normalised to DNA concentration, determined via PicoGreen assay (in a method according to the 224 
manufacturer’s protocol), to account for the effect of variances in cell proliferation.  225 
 226 
Statistical analysis 227 
Each result set is presented as the mean ± S.D. (Standard Deviation) and has been tested for normality, after 228 
undergoing a logarithmic transformation. Differences between treatments were analysed using one-way analysis 229 
of variance (ANOVA) with post hoc Tukey’s test. All statistics were conducted in SPSS version 19 (IBM, 230 
USA). Values of P ≤ 0.05 were considered significant . 231 
 232 
Results 233 
Extract composition and binding 234 
Catechine composition of the GTE (>95 % polyphenols) was analysed by HPLC using external standards for the 235 
main components EGCG, EGC (epigallocatechin), ECG (epicatechingallate) and EC (epicatechin). The main 236 
catechine of the GTE was EGCG (88.5±0.14%). Only minor fractions of other catechines were present in the 237 
order ECG > EGC > EC (i.e., 5.3 ±0.03%, 3.7 ±0.09% and 2.4±0.08%, respectively). WPI was also analysed by 238 
HPLC and consisted primarily of bLG AB (75.7±1.4%), with alpha-Lactalbumin (14.7±0.1%) and <4% bovine 239 
serum albumin (Keppler et al. 2017). 240 
The combination of GTE and WPI resulted in a non-covalent interaction, which was analysed by 241 
ultrafiltration (Figure 1). Of the catechines present, only those which contained an esterified gallic acid, such as 242 
EGCG and ECG, showed a significant interaction with WPI. Furthermore, non-covalent binding of catechines to 243 
WPI decreased with increasing GTE concentration (i.e., 43.7 % of the initial EGCG concentration in 64 µg/ml 244 
GTE was found to interact with 800 µg/ml WPI, whereas only 30.5 % EGCG reacted after addition of 512 245 
µg/ml GTE). ECG bound in a similar way to WPI, although with a slightly lower binding capacity (i.e., 45.3 % 246 
of the initial ECG concentration bound with WPI after addition of 64 µg/ml GTE, and 20.07 % after addition of 247 
512 µg/ml GTE). The loss of catechines due to unspecific membrane interactions and co-precipitation in the 248 
GTE during the ultrafiltration method was acceptable (<22 %).  249 
 250 
Antioxidant and antibacterial effects of GTE and WPI  251 
In the DPPH test (Figure 2), the antioxidative capacity of WPI and GTE were tested by their capacity to 252 
scavenge the free DPPH radical. GTE alone exhibited a scavenging capacity of 20 and 28 % for 64 and 128 253 
µg/ml GTE, respectively. However, the addition of WPI had a significant negative effect on the radical 254 
scavenging capacity of GTE. For example, inclusion of 800 µg/ml WPI reduced inhibition to ~13 and ~24 % for 255 
64 and 128 µg/ml GTE, respectively. There was no radical scavenging effect of WPI alone. 256 
For antibacterial activity, results of MIC (Table 1) determination revealed that in the absence of WPI 257 
the GTE concentrations required to inhibit growth of the bacteria ranged between 128-256 µg/ml. GTE hindered 258 
growth of gram-positive bacteria more strongly than growth of the gram-negative P. aeruginosa. Addition of 259 
WPI decreased the MIC of GTE towards the gram-positive bacteria S. aureus ATCC 700699 and S. epidermidis 260 
ET086, and in particular P. acnes LMG 16711. In contrast, WPI increased the MIC towards the gram-negative 261 
P. aeruginosa ATCC 9027.The growth of the yeast C. albicans ATCC MYA-2876  was not affected by GTE 262 
(MIC >1024 µg/ml, regardless of the addition of WPI). 263 
 264 
Proliferation of fibroblasts and hFOBs  265 
Fibroblasts cultured in the absence of GTE (Figure 3) showed a spindle-like morphology typical of healthy 266 
fibroblasts, as did those exposed to all concentrations of WPI (0, 50 and 800 µg/ml). However, increasing 267 
concentration of GTE appeared to promote the formation of round, apoptotic bodies, indicating the cells were 268 
preparing themselves for phagocytosis and were thus not viable. At a GTE concentration of 64 µg/ml, only a 269 
few apoptotic bodies were observed. At 128 µg/ml GTE larger numbers of dead cells were detected, whilst at 270 
256 µg/ml the majority of cells were dead. Higher GTE concentrations (data not shown) resulted in similar 271 
results as for 256 µg/ml GTE. Increasing WPI concentration to 50 or 800 µg/ml did not lead to an appreciable 272 
reduction in cell death. Hence, GTE concentrations above 128 µg/ml were excluded from further experiments. 273 
For day 1 hFOB cultures, 64 and 128 µg/ml GTE reduced cell proliferation (Figure 4). This effect was 274 
not changed by the addition of WPI. At day 4, 64 and 128 µg/ml GTE reduced cell proliferation, but this 275 
reduction was attenuated by inclusion of 800 µg/ml WPI. At day 7, reduced cell proliferation was again 276 
observed with both 64 and 128 µg/ml GTE, though no attenuating effect of WPI was observed. At all GTE and 277 
WPI concentrations, the decrease in cell proliferation with GTE treatment was not a linear relationship.  278 
WPI appears to promote small increases in cell proliferation, as in the absence of GTE 800 µg/ml WPI 279 
promoted cell proliferation at day 1 and 7. Furthermore, at 64 µg/ml GTE, proliferation was promoted by 800 280 
µg/ml WPI at day 1 and 4; whilst in the presence of 128 µg/ml GTE, 800 µg/ml WPI promoted proliferation at 281 
day 4 only. 50 µg/ml WPI had no significant effect at any time point or  GTE concentration. 282 
Images of hFOBs stained using the crystal violet method (Figure 5) agree with those for fibroblasts 283 
(Figure 3), and support crystal violet assay results (Figure 4). For example, hFOBs cultured in the absence of 284 
GTE formed healthy monolayers, though at a GTE concentration of 64 µg/ml markedly fewer cells were 285 
observed. Of these, some - but not all cells - displayed an elongated morphology, typical of good adhesion. 286 
However, at the highest GTE concentration of 128 µg/ml even fewer cells were observed, providing further 287 
evidence of the inhibitory effect of GTE on cell proliferation. 288 
 289 
Differentiation of hFOB cells 290 
Only 0 and 64 µg/ml concentrations of GTE were used in differentiation experiments, as 128 µg/ml GTE had a 291 
detrimental effect on hFOB proliferation. Day 7 (Figure 6a) timepoint treatments showed the highest overall 292 
levels of alkaline phosphatase (ALP) activity. In WPI subgroup, 64 µg/ml GTE treatments showed significantly 293 
reduced ALP levels compared to those with no GTE. This trend is maintained at all timepoints, with the 294 
exception of the 0 µg/ml WPI subgroup at day 21, where ALP activity is very similar for both GTE treatments. 295 
WPI however shows a bell-shaped response, with 50 µg/ml concentrations causing increased ALP activity 296 
levels, compared to 0 and 800µg/ml treatment wells. These increases for the 50 µg/ml treatment group are 297 




This study aimed to determine the combined effects of GTE and WPI, focusing on traits that would be useful for 302 
bone regeneration materials – such as antimicrobial and antioxidant activity, as well as impacts on osteoblast 303 
growth/differentiation. Firstly, binding assay results showed that significant complexes between GTE and WPI 304 
occurred. This was expected, given that previous studies have reported the binding efficiency of whey proteins 305 
with green tea catechines (Keppler et al. 2015). For example, galloylated cateines, such as EGCG and ECG, 306 
were found to react most strongly with proteins, and exhibited good antioxidative capacity (Bohin et al. 2012). 307 
Due to the nature of the non-covalent reaction, the catechins bound to the protein are always in equilibrium with 308 
unbound catechines, explaining the reported 50% binding of this work. 309 
  GTE’s high radical inhibition capacity was also expected, being mediated by its >95% polyphenol 310 
content, of which most take the form of EGCG (Supplementary Figure 1). Previous studies have shown EGCG 311 
and ECG to be two of the most potent radical scavenging flavonoids present in GTE (Salah et al. 1995; Hirano 312 
et al. 2001). However, the addition of WPI caused a masking effect on GTE scavenging activity, as evidenced 313 
by a decrease in its percentage inhibition. Such an effect on protein-bound polyphenols is probably mediated by 314 
hydrogen bonds, which occur between the hydroxyl groups of the catechines and the protein (Kanakis et al. 315 
2011). A similar masking effect was observed for caseines with green tea catechines using the Trolox equivalent 316 
antioxidant capacity (TEAC) test (Arts et al. 2001), and forbLG and EGCG complexes using the ferric reducing 317 
ability of plasma (FRAP) test (Zorilla et al. 2011). Interestingly, this masking effect on percentage inhibition 318 
observed in the present study amounted to a reduction of approximately 4 to 7%, after the addition of 50 and  319 
800 µg/ml WPI, respectively. However, the binding assay showed an interaction of approximately 50 % of the 320 
GTE. Therefore, it is likely that binding occurs in a way that leaves antioxidative groups of GTE partially 321 
available, even after interaction with the protein.  322 
The main drawback of the DPPH test is the low solubility of DPPH in water, thereby introducing 323 
ethanol into the system, which could denature the WPI. It was reported that denatured whey proteins interact 324 
more readily with GTE catechines (Keppler et al. 2014), which could result in an overestimation of the masking 325 
effect for native WPI. It should be kept in mind that antioxidant assays used here (and in the literature) are 326 
optimized to stabilize the radical in solution, which requires either solvents like ethanol or methanol, or the 327 
addition of different salts.  This will always influence the analysis of antioxidative capacity for protein-328 
polyphenol complexes, because of the sensitivity of non-covalent binding reactions,  which are likely altered 329 
even by the addition of salts or minor pH value changes. 330 
GTE’s anticipated antibacterial activity was confirmed in this study, with its inclusion at concentrations 331 
between 128-256 µg/ml inhibiting the growth of all bacteria tested. This is in agreement with similar work 332 
within the field, whereby GTE extracts of various forms were shown to have diverse antibacterial activity – such 333 
as against S. aureus, S. epidermidis, P. acnes and P. aeruginosa (Lee et al. 2009a; Sharma et al. 2012; Radji et 334 
al. 2013). In the present study, addition of WPI facilitated GTE’s antibacterial activity toward P. acnes LMG 335 
16711, with the MIC decreasing from 128 to 32 µg/ml (50 µg/ml WPI) and even 16 µg/ml (800 µg/ml WPI). A 336 
similar trend was also seen for S. aureus ATCC 700699 and S. epidermidis ET086, though MIC reduction was 337 
much less pronounced and was likely within the tests margin of error. For the Gram-negative Bacterium P. 338 
aeruginosa the opposite effect was seen, whereby addition of WPI gave rise to a drastic increase in MIC (from 339 
256 to 1024 µg/ml). Although the reasons behind the differences observed between Gram-positive and Gram-340 
negative bacteria are unclear, the presence of a second (outer) membrane in Gram-negative bacteria may play an 341 
important role. It can be speculated that protein-bound catechins are less able to interact with peptidoglycan in 342 
the bacterial cell wall, making it difficult for these complexes to cross the outer membrane. EGCG also has a 343 
negative charge, which might be a reason for its lower affinity to Gram-negative bacteria (Yoda et al. 2004). 344 
Furthermore, it should be noted that previous work showed P. aeruginosa to have a MIC twice that of S. aureus 345 
(800 compared to 400 µg/ml) (Radji et al. 2013), which may partly explain the increase in MIC seen after WPI 346 
inclusion. Finally, the fungus, C. albicans, did not respond at all to GTE treatment (MIC >1024 µg/ml). 347 
Previously, it was reported (Hirasawa and Takada 2004) that EGCG had an anti-C.albicans effect, which 348 
increased with increasing pH  and concentration. In our study, pH was 7.4 and the concentration was 1000x 349 
lower, which may explain the lack of response seen. However, the mechanism of GTE’s anti-C. albicans effect 350 
remains unclear. 351 
Good antibacterial and antioxidant capacity are both desirable characteristics for regeneration 352 
materials, helping support a heathy healing site after bone damage. However, cell response also needs to be 353 
determined, to ensure cytocompatibility before clinical application. Fibroblast images  (figure 3) helped to give a 354 
qualitative insight into GTE and WPI’s effect, showing WPI to have no obvious impact on cell adhesion or 355 
morphology. However, increasing GTE concentration caused significant changes in cell morphology, 356 
attachment and increased mortality. This is similar to findings of another study, whereby both normal and keloid 357 
fibroblasts were shown to decrease proliferation in a dose-dependent manner with EGCG treatment (Park et al. 358 
2008). Returning to the present study, fibroblast findings were also mirrored in proliferation results of an 359 
osteoblast-like cell line (hFOB 1.19), whereby 800 µg/ml WPI increased cell growth. Alternatively, GTE 360 
inclusion reduced proliferation, particularly at later time intervals, and this was only partially mitigated by the 361 
addition of WPI. 362 
Field Code Changed
Previous work reports that WPI, especially its component bLG, has a mitotic effect on different cell 363 
types, which would explain its stimulative effect on hFOB proliferation. For instance, Gillespie et al. reported 364 
that bLG (312.5-2500 µg/ml) improved the proliferation of enteroendocrine cells (Gillespie et al. 2015), whilst 365 
another study investigated mouse spleen resting cells. Here, a proliferative effect was found in the concentration 366 
range 50-500 µg/ml, over 12-96 hours (Mahmud et al. 2004). For GTE polyphenols, the literature often reports a 367 
positive effect on bone metabolism, such as increased osteoblast maturation and production of mineralised 368 
material (Ko et al. 2009). Our opposite finding could be due to the different composition of catechins used in 369 
this study, as work by Ko et al. (Ko et al. 2009) did not include EGCG specifically. Alternatively, it may 370 
indicate that even the minimum GTE concentration used in this work was too high, causing suppressive effects 371 
on cell activity. In support of this, other similar studies using osteoblast-like cells tended to use lower 372 
concentrations, compared to the 64 and 128 µg/ml doses of the present study. For example, rat mesenchymal 373 
stem cells (Ko et al. 2011), Saos-2 (Nash and Ward 2016) and human osteoblast cells (Vester et al. 2014) all 374 
showed increased levels of cell differentiation and limited cytotoxicity when treated with GTE concentrations of 375 
around 10 µg/ml (a maximum of 50 and minimum of 0.01 µg/ml). Another similar study, testing EGCG, 376 
demonstrated no toxic effect at 10 µg/ml (Lee et al. 2009b); and whilst higher concentrations are occasionally 377 
tested, exposure times are generally shorter. For example, rat calvarial osteoblasts were treated with green tea 378 
polyphenols at a 200 µg/ml dose, to prevent alterations upon exposure to H 2O2; though only for a 1 hour period 379 
(Park et al. 2003). Returning to the present study, GTE’s inclusion also reduced bLG bioactivity, or 380 
bioavailability, which most likely resulted from binding between the two extracts.  381 
The final indicator of cell activity investigated was ALP, expressed during osteoblast maturation, 382 
which is considered an early marker of osteogenic differentiation (Setzer et al. 2009). Though it was evaluated 383 
on days 7, 14 and 21, the highest ALP activity was measured on day 7, in the 50 µg/ml WPI treatment group. 384 
The consistently high ALP activity in this treatment, compared to 0 and 800 µg/ml, indicates WPI has an 385 
optimal concentration able to stimulate hFOB differentiation. On the other hand, GTE caused a decrease in ALP 386 
activity, often reducing the activity levels by 50% or more in wells with no GTE added. This is in agreement 387 
with a study (Yamaguchi and Ma 2001) concerning the effect of polyphenols on ALP activity in rat femoral 388 
tissues, which concluded that EGCG (0.1 mM) significantly inhibited ALP activity. Furthermore, the current 389 
study’s results appear to support a previously reported  interaction between ALP and polyphenols from the 390 
seaweed-derived nutritional supplement Seanol® (Douglas et al. 2016). Here, a similar concentration of 391 
polyphenols were used in supplements, which were shown to have reduced release rates during ALP-mediated 392 
mineralisation. However, it is important to note there are also several studies where treatment with GTE 393 
increased osteoblast differentiation, such as with the aforementioned work using rat mesenchymal stem cells  394 
(Ko et al. 2011), Saos-2 (Nash and Ward 2016), and human osteoblast cells (Vester et al. 2014). These cells 395 
showed increased levels of many differentiation indicators, including ALP activity, mineralisation levels and 396 
gene expression for proteins including sclerostin, osteopontin and osteocalcin. The contrasting reports of GTE 397 
both inhibiting and promoting cell differentiation are likely a reflection of the overall concentration and 398 
polyphenol content of each extract tested. Finally, in terms of the present study’s interaction effects of GTE and 399 
WPI, GTE again reduced WPI bioactivity. However, the presence of 50 or 800 µg/ml WPI did not obviously 400 
mitigate the negative effect of 64 µg/ml GTE, indicating more WPI binding is needed to promote hFOB 401 
differentiation in these treatments.  402 
Field Code Changed
Field Code Changed
Cell based assay results are arguably the most important when determining a compound or extract’s 403 
suitability for different applications, such as tissue engineering. GTE’s cytotoxicity, whilst slightly mitigated by 404 
WPI, makes it unsuitable for inclusion at sites undergoing skeletal regeneration, as it would likely limit 405 
osteoblast activity. One related limitation of this work was the minimum GTE concentration tested, of 64 µg/ml. 406 
Lower concentrations may have preserved GTE’s antimicrobial and antioxidant capacity, whilst also limiting 407 
cytotoxicity – especially with WPI inclusion. Similarly, further processing of GTE could have been conducted, 408 
to create GTE treatments with different polyphenol compositions and potentially better cytocompatibility.  409 
This work demonstrated the affinity of WPI for components of GTE, and the formation of WPI/GTE 410 
complexes. GTE displayed excellent antioxidative capacity, which was not significantly affected by addition of 411 
WPI; though some masking effect is possible. Furthermore, GTE showed antimicrobial activity against gram-412 
positive and gram-negative bacteria, with WPI inclusion potentiating this effect on several types of gram-413 
positive bacteria. However, with cells GTE showed cytotoxic and suppressive effects on both fibroblasts and 414 
hFOBs, especially at concentrations of 128 µg/ml and above. WPI alone though enhanced hFOB proliferation 415 
and attenuated the suppressive effect of GTE at 64 µg/ml, to a certain extent. For hFOB differentiation, WPI 416 
significantly stimulated ALP activity at a 50 µg/ml concentration, though was less able to attenuate effects of 417 
GTE inclusion. These results therefore show that WPI and GTE both have useful properties, but the cytotoxicity 418 
of GTE makes it unsuitable for inclusion within a tissue engineered construct. 419 
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Figure captions 557 
 558 
Figure 1: GTE compounds that were bound to 800 µg/ml WPI, as a function of the GTE [µg/ml] concentration . 559 
Abbreviations: EGC, Epigallocatechin; EC, epicatechin; EGCG, epigallocatechin gallate, ECG, 560 
epicatechingallate; GTE, green tea extract 561 
 562 
Figure 2: Antioxidative capacity (DPPH test) of different concentrations of GTE, with or without addition of 563 
800 or 50 µg/ml WPI. All values are listed as mean ± standard deviation (n=3). *: p < 0.05 564 
 565 
Figure 3: Images of fibroblasts cultured in cell culture medium containing different concentrations of GTE 566 
(epigallocatechin gallate-rich extract) and WPI (beta-lactoglobulin-rich extract) after 7 d. Scale bar = 100 µm in 567 
all cases. 568 
 569 
Figure 4: Data from day 1 (a), 4 (b) and 7 (c) crystal violet assay conducted on hFOB cells. Results are 570 
presented as the mean optical density values for each treatment, (n=4, +/- SD). * indicates a significant 571 
difference (p<0.05) between the treatment and the 0µg/ml GTE value (within each WPI treatment group). # 572 
indicates a significant difference (p<0.05) between the treatment and the respective  value for WPI = 0 µg/ml. 573 
 574 
Figure 5: Images taken of hFOBs using an ISH500 camera attached to an OLYMPUS SZX10 microscope at 2x 575 
zoom. hFOB cells were fixed and stained with crystal violet 7 days after initial treatment.  Scale bar = 1 mm in 576 
all cases. 577 
 578 
Figure 6: data from an ALP assay conducted on hFOBs. Cells were given a 24 hour attachment period before 579 
being treated with solutions containing different concentrations of GTE and WPI. The assay was conducted on 580 
day 7 (a), day 14 (b) and day 21 (c) timepoints. Each ALP reading was normalized to the DNA concentration of 581 
the same well, calculated via PicoGreen assay. Results are presented as the mean +/ - standard deviation (n=4). 582 
*p<0.05 for WPI treatments at 64 µg/ml GTE, compared to WPI treatments of the same concentration at 0ug/ml 583 
GTE. #p<0.05 for WPI treatment comparisons at 0 µg/ml GTE.  584 
